Daicel Chiral Technologies (India) Pvt. Ltd. (DCTI) is the Indian subsidiary of Japan-based Daicel Corporation, a global leader in chiral chromatography. Established in 2008 at IKP–Hyderabad, DCTI supports pharmaceutical and biopharmaceutical companies through advanced analytical, purification, and synthesis services, working closely with global Daicel teams in the US and Europe.

DCTI’s GMP Analytical Services, inspected by the US FDA and local regulators, offer method development and validation, trace analysis, in-vitro bioequivalence, extractables and leachables (E&L) studies, peptide analytics and oligonucleotides. The company also supports biosimilar comparability studies including structural characterization and functional assays.